Insulin sensitivity in women with polycystic ovary syndrome: relationship to hyperandrogenemia (Q42499652)

1 November 2017

Insulin sensitivity in women with polycystic ovary syndrome: relationship to hyperandrogenemia (English)

1 reference

polycystic ovary syndrome

1 November 2017

1 reference

1 reference

M Rajkhowa

1

1 reference

1 November 2017

J Bicknell

series ordinal

2

1 reference

1 November 2017

M Jones

series ordinal

3

1 reference

1 November 2017

R N Clayton

series ordinal

4

1 reference

1 November 2017

language of work or name

English

0 references

publication date

1 April 1994

1 reference

1 November 2017

Fertility and Sterility

1 reference

1 November 2017

61

1 reference

1 November 2017

4

1 reference

1 November 2017

605-612

1 reference

Polycystic ovaries and polycystic ovary syndrome

1 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956633-3

7 January 2021

Polycystic ovary syndrome: a changing perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956633-3

7 January 2021

Which hormone tests for the diagnosis of polycystic ovary syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956633-3

7 January 2021

Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956633-3

7 January 2021

Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956633-3

7 January 2021

Insulin administration alters gonadal steroid metabolism independent of changes in gonadotropin secretion in insulin-resistant women with the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956633-3

7 January 2021

Suppression of hyperandrogenism does not improve peripheral or hepatic insulin resistance in the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956633-3

7 January 2021

The independent effects of hyperandrogenaemia, hyperinsulinaemia, and obesity on lipid and lipoprotein profiles in women

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956633-3

7 January 2021

Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956633-3

7 January 2021

Insulin resistance in nonobese patients with polycystic ovarian disease

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956633-3

7 January 2021

Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956633-3

7 January 2021

Postprandial thermogenesis is reduced in polycystic ovary syndrome and is associated with increased insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956633-3

7 January 2021

Lack of linear relationship between hyperinsulinaemia and hyperandrogenism

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956633-3

7 January 2021

Body weight, hyperinsulinemia, and gonadotropin levels in the polycystic ovarian syndrome: evidence of two distinct populations.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956633-3

7 January 2021

Insulin resistance in patients with polycystic ovaries: its relationship to body weight and androgen levels.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956633-3

7 January 2021

Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956633-3

7 January 2021

Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956633-3

7 January 2021

A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956633-3

7 January 2021

Estimates of in vivo insulin action in man: comparison of insulin tolerance tests with euglycemic and hyperglycemic glucose clamp studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956633-3

7 January 2021

Plasma free testosterone--is an index sufficient?

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956633-3

7 January 2021

The relation between clinical manifestations of polycystic ovary syndrome and beta-cell function

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956633-3

7 January 2021

10.1016/S0015-0282(16)56633-3

Identifiers

DOI

0 references

1 reference